| ²é¿´: 2549 | »Ø¸´: 31 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
¡¾ÇóÖú/½»Á÷¡¿Çë½Ì´ïÈË£ºÏëÕÒ³öÁ½¸öϸ¾úÖвîÒì±í´ïµÄ»ùÒò£¬ÓÐʲô³ÉÊìÇÒ±ãÒ˵ķ½·¨£¿
|
|||
| ÏÖÓÐÁ½Öêϸ¾ú£¬ÔÝÃüÃûΪ1ºÍ2£¬ÆäÖÐ2¶ÔÓÚijÖÖ¿¹Äæ»·¾³¾ßÓиü¸ßµÄµÖ¿¹Á¦£¬ÏÖÔÚÏëÕÒ³öÔÚÕâÖÖ»·¾³ÏÂÁ½¸ö¾úÖê²îÒì±í´ïµÄ»ùÒò£¬²»ÖªÓÐʲô°ì·¨£¿ÆäÖоú1ÒѾÍê³ÉÁË»ùÒò×é²âÐò£¬¾ú2δ²âÐò£¬ÓÉÓÚ¾·ÑÓÐÏÞ£¬²»Ì«¿ÉÄܲÉÓÃÈ«»ùÒò×éоƬ·½·¨£¬Çë½Ì¸÷λ´ïÈË£¬ÓÐʲô¼È±ãÒËÓֱȽϳÉÊìµÄ·½·¨£¿²»Ê¤¸Ð¼¤£¡ |
» ²ÂÄãϲ»¶
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖеÄȤÊ£ºÊµÑéÆ÷²ÄµÄ ¡°ÎÚÁú¡±
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖеÄȤÊ£ººÍʵÑé²ÄÁ쵀 ¡°¶·ÖǶ·Ó¡±
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ205È˻ظ´
µ°°×Öʼì²â£º¾«×¼·ÖÎö£¬½âËøÉúÎï·Ö×ÓµÄÃÜÂë
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑé֮СÊóʵÑ飺ÑϽ÷Éè¼Æ£¬½âÎöÉúÃü»úÖÆµÄÖØÒªÔØÌå
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®ÖØ½ðÊô¼ì²â£º¾«×¼É¸²é£¬ÊØ»¤½¡¿µÓë»·¾³µÄ·ÀÏß
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÍܲâÖØ½ðÊôÎÒ±³¹øÈýǧ¡±
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÊóÌÓÈý´ÎÎÒ·¢ÈýƪSCI¡±
ÒѾÓÐ0È˻ظ´
ÄÉÃ×Á£¶È·ÖÎö
ÒѾÓÐ3È˻ظ´
ÁÖ¿ÆÔºÁÖ»¯ËùÕÐÊÕ²ÄÁÏÓ뻯¹¤×¨ÒµË¶Ê¿£¬×ø±êÄϾ©
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Çë½ÌÓлú»úÖÆ´ïÈË£¬Ò»¸ö·´Ó¦»úÀí~~~~
ÒѾÓÐ8È˻ظ´
½ð±ÒÇë½Ì´ïÈËÒ»Çó·½²îµÄÎÊÌ⣬ʮ·Ö׿±£¬Òª¿¼ÊÔÁË£¡
ÒѾÓÐ16È˻ظ´
¹òÇó¸ÅÂÊÂÛ´ïÈËÎÊÌâÓйØversionµÄÎÊÌ⣡£¡£¡
ÒѾÓÐ4È˻ظ´
ÓйØ2012cscÉêÇëµÄ¼¸¸öÎÊÌ⣬Çë´ïÈËÓ»Ô¾»Ø´ð
ÒѾÓÐ21È˻ظ´
Çë½ÌÓоÑéµÄÓлú´ïÈË¡ª¡ª¹ýÖù·ÖÀëÎÊÌâ
ÒѾÓÐ10È˻ظ´
´óÇåÔç·¢¸öÇóÖúÌû£¬Çó΢ÉúÎï´ïÈË´ÓÐÎ̬Éϼø±ðÒ»ÏÂÕâÊÇʲô¾ú
ÒѾÓÐ19È˻ظ´
ÇëÎÊÉêÇë±±ÃÀÁôѧpaperµÄ¼ÛÖµÎÊÌ⣬Çó´ïÈ˰ïæ
ÒѾÓÐ7È˻ظ´
Çë´ïÈ˰ïæ¿´Ò»Ï£¬±à¼ÈçϵľܸåÀíÓÉÄÜ·ñdebateÒ»ÏÂ
ÒѾÓÐ6È˻ظ´
¡¾ÌÖÂÛ¡¿Çë½Ì´ïÈË£º»ìºÏ±íÃæ»îÐÔ¼ÁµÄŨÈÜҺΪʲôºÜÈÝÒ×»á½áƤ£¿
ÒѾÓÐ7È˻ظ´
¡¾ÇóÖú¡¿Ïò¸÷λǰ±²´ïÈËÇë½Ì»§¿ÚÎÊÌâ
ÒѾÓÐ10È˻ظ´
¶ÔÓÚÒ»¾ä»°µÄÀí½â~~´ïÈ˰ï°ï棡£¡£¡
ÒѾÓÐ3È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿16s½ø»¯Ê÷+ϸ¾ú¼ø¶¨ ´ïÈË Çë½ø~~~
ÒѾÓÐ5È˻ظ´
¡¾ÇóÖú¡¿ÇëÎʸ÷λʳƷ´ïÈË£¬Ë®ÖÐ×ܴ󳦾úȺÈçºÎ²â¶¨£¿
ÒѾÓÐ8È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
ÕÐÊÕ²ÄÁÏÓ뻯ѧÏà¹Ø×¨ÒµË¶Ê¿Ñо¿Éú
+1/87
ÎÄÏ×·ÖÏí£¬»¶ÓÒýÓÃ
+1/86
»ªÄÏʦ·¶´óѧ£¨211£©²©Ê¿ÕÐÉú- µç×Ó¡¢×Ô¶¯»¯¡¢»úе¡¢ÉúÎïѧ¡¢ÎïÀíÏà¹Ø×¨Òµ
+2/40
ÉϺ£½»Í¨´óѧÉòµÀÖǸ±½ÌÊÚÕÐÊÕ2026ÄêÁªÅ಩ʿ/˶ʿÑо¿Éú£¨Î¢ÄÉÆ÷¼þÓëÖÆÔì·½Ïò£©
+1/33
»ªÄÏʦ·¶´óѧ£¨211£©ÉêÇëÉóºËÖÆ²©Ê¿ÕÐÉú- µç×Ó¡¢×Ô¶¯»¯¡¢»úе¡¢ÉúÎïѧ¡¢ÎïÀíÏà¹Ø×¨Òµ
+1/23
ºþÄÏ´óѧ΢ÉúÎï½á¹¹Ó빦ÄÜʵÑéÊÒ2026Äê¼Æ»®ÕÐÊÕ²©Ê¿Ñо¿Éú
+1/16
ÄÏ¿ª´óѧ³ÂÊ÷ç÷½ÌÊÚÑо¿ÍŶÓÕÐÊÕ2026¼¶³¬¹¹²ÄÁÏ·½Ïò²©Ê¿Ñо¿Éú
+1/14
2026ÄêÎ÷ÄϿƼ¼´óѧ¹¦ÄÜÍ¿²ã¿ÎÌâ×é¼ò½é
+1/10
ÄϾ©Ò½¿Æ´óѧ-Ĥµ°°×½á¹¹Ó빦ÄÜ¿ÎÌâ×é-ÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú
+1/10
ÉîÛÚÐÅÏ¢Ö°Òµ´óѧÕÐÆ¸ÁªºÏÅàÑøË¶²©Ñо¿Éú£¨¼±£©
+1/10
¡¾¿ÆÑиɻõ¡¿ÄÉÃ׿¹ÌåÆ¾Ê²Ã´³ÉΪʵÑéÊÒ¡°Ð³衱£¿¸½ÓÅÖÊÖÆ±¸·þÎñÉ̲ο¼
+1/7
¸£ÖÝ´óѧ¹ú¼Ò¼¶È˲ÅÌÀÓýÐÀ½ÌÊÚ¿ÎÌâ×é2026ÄêÕÐÊÕ¡±ÉêÇ뿼ºËÖÆ¡°´¢ÄÜµç³Ø·½Ïò²©Ê¿Ñо¿Éú
+1/6
»¶ÓÉúÎïÓëÒ½Ò©¡¢Ò©Ñ§¡¢»¯Ñ§µÈÏà¹Ø×¨ÒµµÄͬѧ
+1/5
ÉϺ£½»Í¨´óѧ»úеÓ붯Á¦¹¤³ÌѧԺ²©Ê¿ºóÕÐÆ¸
+3/5
Öйú¿ÆÑ§Ôº¹ý³Ì¹¤³ÌÑо¿ËùÖúÀíÑо¿Ô±£¨Õýʽְ¹¤£©ºÍ²©Ê¿ºóÕÐÆ¸ÆôÊÂ
+1/4
Ò׶ȲãÁ÷ÖÊÁ¿Á÷Á¿¿ØÖÆÆ÷ÔÚÍп¨Âí¿ËºË¾Û±ä×°ÖÃÖеÄÓ¦Óð¸ÀýÓëºËÐÄÓÅÊÆ
+1/4
2026¿¼ÑеÄͬѧ£¬·ÖÊý²»¹»£¿Ïëµ÷¼ÁÉϰ¶µÄͬѧ£¬À´¿´
+1/3
¸£½¨Ê¦·¶´óѧ»¯Ñ§Óë²ÄÁÏѧԺ¶Å¿ËîÈÍŶӲ©Ê¿ÕÐÉú
+2/2
»¶Ó¼ÓÈë¸ÓÄÏʦ·¶´óѧÏȽø¹âµç×ÓÑо¿ÖÐÐÄ
+1/2
Õò½Íжû»¯Ñ§ÓлúºÏ³ÉÑз¢¸Úλ¹¤×÷»ú»á
+1/1
xp198766
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- MolEPI: 1
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ½ð±Ò: 6525.1
- Ìû×Ó: 2193
- ÔÚÏß: 554Сʱ
- ³æºÅ: 1046859
¡ï
qinjysdu(½ð±Ò+2):лл²ÎÓë
qinjysdu(½ð±Ò+2):лл£¬Õâ¸ö·½·¨¾ÍÅÂ×Ô¼ºÕÒ³öµÄ¿ÉÄܵĻùÒòûÓаüº¬Êµ¼ÊµÄ²îÒì»ùÒò£¡ 2010-12-08 08:30:35
qinjysdu(½ð±Ò+2):лл²ÎÓë
qinjysdu(½ð±Ò+2):лл£¬Õâ¸ö·½·¨¾ÍÅÂ×Ô¼ºÕÒ³öµÄ¿ÉÄܵĻùÒòûÓаüº¬Êµ¼ÊµÄ²îÒì»ùÒò£¡ 2010-12-08 08:30:35
| ¿É²»¿ÉÒÔÔÚ¿¹ÄæÌõ¼þÏÂÌáRNA£¬ÕÒЩ¿ÉÄܵĻùÒò×öqPCR¿´¿´~~~~ |
3Â¥2010-12-07 22:33:42
¡ï
qinjysdu(½ð±Ò+2):лл²ÎÓë
qinjysdu(½ð±Ò+5):лл£¬¸Ã·½·¨Ó¦¸Ã¿ÉÐУ¡ 2010-12-08 08:29:19
qinjysdu(½ð±Ò+2):лл²ÎÓë
qinjysdu(½ð±Ò+5):лл£¬¸Ã·½·¨Ó¦¸Ã¿ÉÐУ¡ 2010-12-08 08:29:19
| ²»ÖªµÀ²î¼õÔÓ½»ÊDz»ÊÇ¿ÉÒÔ |
4Â¥2010-12-07 23:34:29
wangleisdnu
½ð³æ (ÕýʽдÊÖ)
- MolEPI: 2
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ¹ó±ö: 0.001
- ½ð±Ò: 992.2
- Ìû×Ó: 407
- ÔÚÏß: 131.3Сʱ
- ³æºÅ: 89944
¡ï ¡ï ¡ï
qinjysdu(½ð±Ò+2):лл²ÎÓë
rainwander(½ð±Ò+2):¹ÄÀø»ý¼«²ÎÓë~ 2010-12-08 08:15:07
qinjysdu(½ð±Ò+2):лл²ÎÓë
rainwander(½ð±Ò+2):¹ÄÀø»ý¼«²ÎÓë~ 2010-12-08 08:15:07
|
Non-radioactive RNA fingerprint procedure First strand cDNA synthesis was performed with 15 mg of total RNA, 500 pmol oligo(dT)18 and 800U Superscript II reverse transcriptase (Life Technologies) in a volume of 100ml RT buffer, following the manufacturer¡¯s instructions. After heat inactivation of reverse transcriptase and RNase A digestion, reaction products were purified from excess oligonucleotides by using a QIAquick kit (Qiagen). cDNA derived from 75 ng of total RNA was used as template for PCR. Amplification was performed in 20 ml of PCR buffer (10mM Tris-Cl pH 8.3, 50mM KCl, 1.5mM MgCl2) with 125mM dNTPs (Pharmacia) and 1mM each primer. For each reaction, two 18-mer oligonucleotides, of arbitrary sequence and a GC content of 61%, were used. Sequences of all 131 oligonucleotides used in this screen can be obtained upon request. All PCR amplifications were performed on an Omni-Gene thermal cycler (Hybaid). After 2 min of denaturation at 948C, 2 units of Taq DNA polymerase (Roche) were added (manual ¡®hot start¡¯). After 1 min at 948C, the profile was started with two, low-stringency cycles (948C for 1.5 min, 508C for 3.5 min and 728C for 3 min) followed by 35¨C40 high-stringency cycles (948C for 1 min, 658C for 1 min, and 728C for 1 min), and a final 5 min extension at 728C. Reaction products were separated on 2% SeaKem LE agarose gels (FMC) for 3.5 h at 6¨C 7Vcm21 and 88C. Gel and running buffer was 0.5X TBE (50mM Tris-borate pH 7.9, 1mM Na2-EDTA) containing 5mgml21 ethidium bromide. Bands of interest were excised, DNA was eluted with a Jetsorb kit (Genomed) and the amplicons were cloned directly by using a Topo TA cloning kit (Invitrogen). ÕâÖÖ·½·¨±È½ÏµÄÔʼ£¬Ó¦¸Ã±È½ÏµÄ±ãÒË |
5Â¥2010-12-08 04:32:53
6Â¥2010-12-08 08:33:07













»Ø¸´´ËÂ¥